We integrate established practices with technological innovations to drive superior financial performance. We turn vision into reality by combining time-tested processes and progressive practices to generate long-term results. From identifying and funding promising healthcare companies through Santé Ventures, to the systematic use of artificial intelligence at Santé Capital, everything we do reflects our technology-first approach to achieving superior fund performance for a brighter future.
Founded in 1999, Syntheon is a well-known medical device incubator. Many of the industry’s most trusted and admired companies, such as Boston Scientific, Edwards Lifesciences, Johnson & Johnson, Medtronic, and Olympus, have acquired our proprietary technologies. From cardiology to interventional neurology, at the heart of all we do are patients whose lives are improved by our products. We do it by combining the best of two proven and successful strategies that continue to serve us well. New opportunities are discovered working with physicians, developing products through FDA approval and release. Additionally, we partner synergistically with leading companies in all fields to create, enhance and leverage our expertise, capability, and experience.
Proven, Trusted Investors in Healthcare Innovation. With over two decades of experience as early stage VC company builders, Hatteras Venture Partners has constructed a risk-mitigated, replicable value creation model. The cutting-edge companies we focus on range from those delivering therapeutic or diagnostic benefits to patients to companies disrupting the status quo in healthcare and accelerating the pace of innovation.
Epidarex Provides Equity Capital to Start-Ups, Including University Spin-outs. Through our deep scientific and industry network we are able to identify transformative life science investments in under-ventured regions of the US and UK, building companies from scratch to create value and shared success.
Founded in 2008, Broadview Ventures is a mission-driven investment organization. Broadview’s primary goal is to improve human health in the areas of cardiovascular disease and stroke through investments in early stage companies developing innovative therapeutics, devices, and diagnostics.
Copyright © 2021 RapidPulse, Inc. - All Rights Reserved.